VFA
ABMD

Valeo Financial Advisors’s Abiomed Inc ABMD Stock Holding History

Valeo Financial Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65
Closed -$21K – 2024
2021
Q1 		$21K Hold
65
– – ﹤0.01% 1155
2020
Q4 		$21K Hold
65
– – ﹤0.01% 1021
2020
Q3 		$18K Sell
65
-276
-81% -$79.5K ﹤0.01% 949
2020
Q2 		$82K Buy
341
+9
+3% +$1.81K 0.01% 573
2020
Q1 		$52K Sell
332
-34
-9% -$5.64K 0.01% 600
2019
Q4 		$62K Sell
366
-32
-8% -$5.93K 0.01% 573
2019
Q3 		$73K Sell
398
-18
-4% -$3.89K 0.01% 506
2019
Q2 		$108K Sell
416
-83
-17% -$22K 0.01% 416
2019
Q1 		$143K Buy
499
+126
+34% +$41.9K 0.02% 343
2018
Q4 		$121K Buy
373
+323
+646% +$112K 0.02% 346
2018
Q3 		$17K Buy
+50
New +$19.7K ﹤0.01% 834

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Valeo Financial Advisors's ABMD Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 65 shares — an estimated $21K sold.

Valeo Financial Advisors first reported a position in ABMD in Q3 2018 and held it in 11 quarters. The position peaked at $143K in Q1 2019. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 65 Abiomed Inc shares in Q2 2021, an estimated $21K.
  • Valeo Financial Advisors first reported a position in Abiomed Inc in Q3 2018 and held it in 11 quarters.
  • Valeo Financial Advisors's Abiomed Inc position peaked at $143K in Q1 2019.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.